Ocugen (OCGN) EBT Margin (2014 - 2026)
Ocugen's (OCGN) quarterly EBT Margin came in at 2339.14% in Q1 2026, down 129538.0% YoY from N/an in Q1 2025, and down 125.03% on a QoQ basis from 9344.04% in Q4 2025.
Ocugen (OCGN) EBT Margin (2014 - 2026) Analysis & Trends
Ocugen (OCGN) has 7 years of EBT Margin data on file, last reported at 2339.14% in Q1 2026.
- Quarterly EBT Margin fell 129538.0% year-over-year to 2339.14% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2077.65% (down 67639.0% YoY) and the FY2025 annual result came in at 4487.63%, down 21949.0% from the prior year.
- EBT Margin eased to 2339.14% in Q1 2026, from 9344.04% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 9344.04% in Q4 2025 to a low of 8796.17% in Q4 2023.
- A 5-year average of 2443.38% and a median of 1839.18% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2023 — EBT Margin slumped 630026 bps — and 2025, when it surged 1116878 bps.
- Tracing OCGN's EBT Margin over 5 years: stood at 2495.9% in 2022, then slumped by 252 bps to 8796.17% in 2023, then soared by 79 bps to 1824.74% in 2024, then soared by 612 bps to 9344.04% in 2025, then plunged by 125 bps to 2339.14% in 2026.
- The last three EBT Margin figures came in at 2339.14% (Q1 2026), 9344.04% (Q4 2025), and 1069.18% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Ocugen | 457.71 Mn | 357.61 Mn | - | -1,769.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,769.35% |
| Mar 31, 2026 | -2,339.14% |
| Dec 31, 2025 | 9,344.04% |
| Sep 30, 2025 | -1,069.18% |
| Jun 30, 2025 | -1,467.01% |
| Mar 31, 2025 | -1,043.75% |
| Dec 31, 2024 | -1,824.74% |
| Sep 30, 2024 | -1,142.69% |
| Jun 30, 2024 | -1,839.18% |
| Mar 31, 2024 | -1,815.29% |
| Dec 31, 2023 | -8,796.17% |
| Sep 30, 2023 | -456.02% |
| Jun 30, 2023 | -5,807.63% |
| Mar 31, 2023 | -5,158.47% |
| Dec 31, 2022 | -2,495.90% |
| Sep 30, 2022 | -4,704.29% |
| Jun 30, 2022 | -4,222.40% |
| Mar 31, 2022 | -6,699.60% |
| Jun 30, 2020 | -8,404.65% |
| Sep 30, 2014 | -4.99% |